Search for: "Eli, Inc."
Results 601 - 620
of 1,001
Sorted by Relevance
|
Sort by Date
27 Aug 2011, 7:55 pm
Eli Lilly v. [read post]
2 May 2011, 3:14 pm
Eli Lilly & Co., 598 F.3d 1336, 1351 (Fed. [read post]
16 Sep 2008, 4:35 am
Gen-Probe Inc., 323 F.3d 956, 963 (Fed. [read post]
16 Jul 2012, 10:17 am
In Eli Lilly & Co. v. [read post]
1 Feb 2007, 6:07 am
Eli Lilly & Co., 1420 A.2d 1305, 1320 (N.J. [read post]
1 Jul 2010, 5:00 am
Eli Lilly & Co., 394 N.E.2d 1369 (Ill. [read post]
19 Sep 2013, 9:53 am
Pfizer, Inc., 712 F.3d 21 (1st Cir. 2013), Aetna, Inc. v. [read post]
6 Nov 2020, 7:16 am
” (quoting appellant’s brief); See also Eli Lilly and Co. v. [read post]
30 Nov 2021, 9:36 am
Eli Lilly & Co., 598 F.3d 1336 (Fed. [read post]
23 Sep 2017, 12:39 pm
Cir. 2015); Eli Lilly, 845 F.3d at 1370. [read post]
17 Sep 2011, 5:43 am
The lawsuit alleges that Actos' manufacturer, Takeda Pharmaceuticals North America (and other entities including: Takeda Global Research & Development Center Inc., Takeda Pharmaceuticals Company Ltd., Takeda Pharmaceuticals America, Takeda San Diego Inc., Takeda Pharmaceuticals International Inc and Eli Lilly and Company), was negligent for not providing any warnings regarding the increased bladder cancer risk associated with Actos use. [read post]
1 Apr 2008, 10:57 am
Swami, Inc. [read post]
31 Oct 2011, 3:42 am
A. v Kookmin Bank, heard 27 July 2011, and Human Genome Sciences Inc v Eli Lilly and Company, heard 18 – 21 July 2011. [read post]
15 May 2017, 1:00 am
Eli Lilly & Co v Actavis UK Ltd & Ors, heard 4-6 Apr 2017. [read post]
14 Oct 2013, 4:15 am
Universal Electronics Inc. [read post]
27 Jan 2008, 10:21 am
Ely Western District of Michigan at Grand Rapids 08a0073n.06 USA v. [read post]
20 Jan 2011, 4:50 pm
MBO Labs., Inc. v. [read post]
9 Apr 2009, 7:52 am
(IP Think Tank) Brazilian public-private partnerships in the pharma industry (IP tango) EU: ECJ to rule on reference on SPC Regulation interpretation from Lithuania in Kirin Amgen, Inc. v Lietuvos Respublikos valstybinis patentų biuras (The SPC Blog) India: Delhi High Court Dasatinib order: Is patent-drug regulatory linkage a necessity? [read post]
24 Feb 2010, 2:11 am
(IP Watch) Exploring a new angle in the TRIPS and drug patents debate (Spicy IP) EPO Enlarged Board of Appeal rules on patenting a method of treatment by surgery: G1/07 (IPKat) (EPLAW) (Patent Baristas) EPO Enlarged Board of Appeal decides on dosage regime – Swiss-type claims no longer available: G 2/08 – Dosage Regime/Abbot Respiratory (EPLAW) (Managing Intellectual Property) (IPKat) (Patent Baristas) India: Victory for access to medicines as Bayer loses lawsuit in India (GenericsWeb)… [read post]
24 Feb 2010, 2:11 am
(IP Watch) Exploring a new angle in the TRIPS and drug patents debate (Spicy IP) EPO Enlarged Board of Appeal rules on patenting a method of treatment by surgery: G1/07 (IPKat) (EPLAW) (Patent Baristas) EPO Enlarged Board of Appeal decides on dosage regime – Swiss-type claims no longer available: G 2/08 – Dosage Regime/Abbot Respiratory (EPLAW) (Managing Intellectual Property) (IPKat) (Patent Baristas) India: Victory for access to medicines as Bayer loses lawsuit in India (GenericsWeb)… [read post]
